StockData
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd (TLSA) stock

TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 1, 2026Score 3/30
$0.81+0.16 (+24.75%)

Close on Nov 18, 2026Market cap $97.42MP/E –Yield –

Tiziana Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$21.13M. The highest annual figure on record is -$9.87M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.13M–
FY2024Dec 31, 2024-$15.79M–
FY2023Dec 31, 2023-$17.98M–
FY2022Dec 31, 2022-$14.59M–
FY2021Dec 31, 2021-$27.37M–
FY2020Dec 31, 2020-$28.03M–
FY2019Dec 31, 2019-$9.92M–
FY2018Dec 31, 2018-$9.87M–
FY2017Dec 31, 2017-$10.49M–
FY2016Dec 31, 2016-$9.88M–

More Tiziana Life Sciences figures

See a number that looks wrong?